In dire present times, with the threat of COVID-19 looming over, automated immunoassay analyzers market, one of the many sub-spheres of the global healthcare space, has been gaining a lot of prominence. Immunoassay analyzers generally use antibodies as reagents to identify the number of certain substances in a sample – this is particularly why they have been garnering a lot of traction during the COVID-19 phase.
In dire present times, with the threat of COVID-19 looming over, automated immunoassay analyzers market, one of the many sub-spheres of the global healthcare space, has been gaining a lot of prominence. Immunoassay analyzers generally use antibodies as reagents to identify the number of certain substances in a sample – this is particularly why they have been garnering a lot of traction during the COVID-19 phase. The prevalence of R&D programs and increased expenditure on the same have been major factors pushing the growth of this industry.
Recently in August 2020, the Journal of Medical Virology published a study where a hundred samples taken from subjects who tested negative for COVID‐19 had been analyzed to evaluate the diagnostic specificity of Ab (antibody) detection. The results of the clinical study reveal that automated chemiluminescent immunoassay analyzer can prove highly useful for quantitative measurement of antibodies in Covid-19 patients. Besides their demonstrated usefulness, automated immunoassay analyzers are also less expensive and deliver faster results when compared with alternative methods.
According to Global Market Insights, Inc., the automated immunoassay analyzers market is projected to be valued at $25 billion by 2024.
Improved medical outcome generating greater demand
The demand for automated immunoassay analyzers in laboratories and hospitals has been increasing a lot lately, as they ensure the accuracy of reports, simultaneously making the lab procedures more efficient. The high sensitivity of automated immunoassay analyzers makes them an apt asset to the medical staff during these onerous times, as these instruments can aid in precisely detecting the infected population.
In this regard, it is vital to mention that chemiluminescence immunoassay analyzers will command a major share in the revenue, with an anticipated CAGR of 16.4% through the projected period. These analyzers, as a matter of fact, are known to considerably speed up the efficiency and competence of operations in labs and hospitals, by means of identifying over hundreds of analytes on an hourly basis.
The consistent scenario posed by the spread of Covid-19
Outbreak of infectious diseases such as the present-day Covid-19 pandemic is expected to be a pivotal driving factor for enhancing the market outlook. As the number of Covid-19 patients has been rising with every passing day, the necessity for improved testing, both qualitatively and quantitatively, has provided an impetus to the global automated immunoassay analyzers market share. Manual operation and a smoother workflow assured by the usage of automated immunoassay analyzers is of key significance, especially today when hospitals, clinics, and laboratories are striving to manage with a limited number of staff.
To access sample pages of this report titled, “Automated Immunoassay Analyzers Market Size By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme Linked Fluorescent System, Multiplexed Assay System, Radioimmunoassay), By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast 2024” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/1727
Europe market to expand steadily given the rise in infectious disease prevalence
With UK leading the pack, the Europe automated immunoassay analyzers market is expected to garner significant revenue over the next few years. It was valued at $767.8 million in 2017. Rising prevalence of infectious diseases in the region will lead to an increase in the regional market size. Almost $30 million was spent on health and economic burden in the UK in 2017, following a surge in infectious diseases. The pandemic is expected to bring about a further upsurge in the demand for automated immunoassay analyzers in the region.
Endocrinology segment to witness marked growth
In terms of the application landscape, the global automated immunoassay analyzers industry will witness significant expansion from the endocrinology segment. Having held a valuation of $1,641.3 million in 2017, the segment is expected to soar in the coming times. This can be credited to the rising endocrine disorders.
As the vulnerability of the adolescent population to hormonal imbalances worsens, the endocrine glands get affected, leading to endocrine dysfunction. Some of the common endocrine disorders include diabetes, hyperthyroidism, hypothyroidism, Addison’s disease, and Cushing’s syndrome.
F. Hoffmann-La Roche AG, BioMerieux SA, Becton Dickinson (BD), Abbott Diagnostics, Luminex Corporation, and Biokit are some of the key players in the market for automated immunoassay analyzers. A propensity to focus on introducing products featuring cutting-edge technology is a major strategy among the leading players. These companies are also looking to enhance their product portfolio so as to cater to the diverse requirements of laboratories in terms of budget, test volume, automation level, and assay menu.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com